The Lancet Oncology · 2019 · 254 citations · 26 references
MedicineOncologyPharmacotherapyImmuno-oncology PharmacotherapyImmunotherapyPrecision OncologyCancer ImmunotherapyCheckpoint Inhibitor TherapyImmunotherapy For Urologic CancersKidney CancerRenal Cell CarcinomaToxicity ManagementMetastatic Renal Cell Carcinoma TherapyRenal Cell Carcinoma Systemic Therapy
26
EuroQol - a new facility for the measurement of health-related quality of life
Health Policy · 1990 · 15.8K citations
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
Robert J. Motzer, Bernard Escudier, Saby George et al. · New England Journal of Medicine · 2015 · 5.9K citations · Full text
Medicine, Oncology, Pharmacotherapy +17
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
Robert J. Motzer, Thomas E. Hutson, Piotr Tomczak et al. · New England Journal of Medicine · 2007 · 5.8K citations · Full text
Medicine, Oncology, Pharmacology +14
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
Jedd D. Wolchok, Vanna Chiarion‐Sileni, René González et al. · New England Journal of Medicine · 2017 · 5.4K citations · Full text
Pharmacy, Oncology, Pharmacotherapy +17